Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
William White is listed as Senior Biotech Executive specializing in the pre and post commercialization of rare / orphan disease and gene and cell therapy. at Abeona Therapeutics, a with 92 employees, based in Scottsdale, Arizona, United States. AeroLeads shows a matched LinkedIn profile for William White.
William White previously worked as Vice President of Market Access at Abeona Therapeutics and Sr. Vice President, Head Market Access and Pricing at Brainstorm Cell Therapeutics. William White holds Bachelor Of Science In Business Administration, Marketing from Rider University.
This section adds company-level context without repeating William White's masked contact details.
Review company-level records connected to William White before choosing the right outreach path.
PROFESSIONAL INTENTHighly motivated biotech executive with extensive experience in commercial leadership roles with dynamic, upstart organizations. Expertise and a strong track record of success driving the successful introduction and growth of innovative and groundbreaking therapeutic solutions. Results oriented leader with a proven ability to bridge the gap between R&D and successful commercial launches optimizing product sales and profitability. Expertise: rare and orphan conditions, gene and cell therapy, neurodegenerative disease, payer engagement, market analysis, KOL development, patient access, pricing, reimbursement, contracting, vendor management, trade and distribution, Patient Services / HUB design and implementation, training and development, performance management, incentive compensation, C-Suite cross-functional leadership, and building, leading, and developing high performing teams.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Scottsdale, Arizona, United States
Lead the market access strategy and execution of Abeona's lead candidate, prademagene zamikeracel (pz-cel), an autologous, engineered cell therapy for the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB).
United States
• Report directly to the Chief Executive Officer• Assumed all commercialization responsibilities from previous Chief Commercial Officer.• Lead the commercial access strategy for lead autologous cell therapy candidate for the treatment of ALS.• Develop, deliver, and execute complete RFP process for patient services providers to support launch. • Negotiate and manage Commercialization partner on key deliverables including market access landscape, value and access strategy, reimbursement, pricing and contracting, government reporting and field support.• Uncover and present potential partnership opportunities through various business development deals.• Selected as Industry representative panelist at the PCMA annual meeting, September 2022, to discuss and debate the topic of “how manufacturers and payers can collaborate to support patient outcomes.”* downsized due to negative FDA Advisory Committee outcome leading to organizational restructuring and BLA being pulled from consideration.
Formerly Avexis
* Highly successful launch of the highest priced therapy ever developed at the time, Zolgensma, a Gene Replacement Therapy (GRT) for the treatment of Spinal Muscular Atrophy in infants. * Department Head for Market Access and Patient Support Services teams (26) inclusive of National Account Directors, Field Reimbursement Managers, Patient Access Managers (Nurse Navigator), and Contracting Director.
Deerfield, Illinois, United States
Channel, Distribution, and Market Access Launch strategy development for a novel gene therapy treatment for a rare genetic neurological condition, Spinal Muscular Atrophy (SMA).
Chandler, Az.
ELAN ACQUISITION of DURA PHARMACEUTICALS - February 2000Promoted to Sales Management - May 2000
Other employees you can reach at abeonatherapeutics.com. View company contacts for 92 employees →
Sawyer Baker
Colleague at Abeona TherapeuticsCleveland, Ohio, United States
View →
GH
Geoffrey Hubbard
Colleague at Abeona TherapeuticsDallas, Texas, United States
View →
BI
Ben Ingersoll
Colleague at Abeona TherapeuticsGreater Cleveland, United States
View →
EW
Ethan Whiteford
Colleague at Abeona TherapeuticsGreater Cleveland, United States
View →
JD
Julie Deja
Colleague at Abeona TherapeuticsCleveland, Ohio, United States
View →
GB
Grace Bizzell
Colleague at Abeona TherapeuticsGreater Cleveland, United States
View →
SM
Sara Melton
Colleague at Abeona TherapeuticsNaples, Florida, United States
View →
SM
Steven Milosic
Colleague at Abeona TherapeuticsCleveland, Ohio, United States
View →
PW
Paul Wille
Colleague at Abeona TherapeuticsGreater Cleveland, United States
View →
RW
Ryan Wolford
Colleague at Abeona TherapeuticsGreater Cleveland, United States
View →
Quick answers generated from the profile data available on this page.
William White works for Abeona Therapeutics.
William White is listed as Senior Biotech Executive specializing in the pre and post commercialization of rare / orphan disease and gene and cell therapy. at Abeona Therapeutics.
William White is based in Scottsdale, Arizona, United States while working with Abeona Therapeutics.
William White has worked for Abeona Therapeutics, Brainstorm Cell Therapeutics, Novartis Gene Therapies, Avexis Inc, and Insys Therapeutics, Inc..
William White's colleagues at Abeona Therapeutics include Sawyer Baker, Geoffrey Hubbard, Ben Ingersoll, Ethan Whiteford, and Julie Deja.
You can use AeroLeads to view verified contact signals for William White at Abeona Therapeutics, including work email, phone, and LinkedIn data when available.
William White holds Bachelor Of Science In Business Administration, Marketing from Rider University.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the William White you were looking for.
